Suchergebnisse - "Fanti, S"

PubPharm (18)

1

Optimal timing and criteria of interim PET in DLBCL : a comparative study of 1692 patients

enthalten in: Blood advances | 2021

von Eertink, J. | Burggraaff, C. | Heymans, M. | +22

2

First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma : a phase 2 study of the Fondazione Italiana Linfomi

enthalten in: Blood cancer journal | 2019

von Broccoli, A. | Argnani, L. | Botto, B. | +8

3

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Horwich, A. | Babjuk, M. | Bellmunt, J. | +98

4

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

enthalten in: Leukemia | 2016

von Zamagni, E. | Nanni, C. | Gay, F. | +27

5

Management of patients with advanced prostate cancer : recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Gillessen, S. | Omlin, A. | Attard, G. | +41

CommentIn: Ann Oncol. 2015 Nov;26(11):2354. - PMID 26216387

6

Searching for signatures of cold adaptations in modern and archaic humans : hints from the brown adipose tissue genes

enthalten in: Heredity | 2014

von Sazzini, M. | Schiavo, G. | De Fanti, S. | +3

7

Development and validation of RAYDOSE : a Geant4-based application for molecular radiotherapy

enthalten in: Physics in medicine and biology | 2013

von Marcatili, S. | Pettinato, C. | Daniels, S. | +4

8

Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I

enthalten in: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of | 2012

von Pettinato, C. | Monari, F. | Nanni, C. | +7

9

A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Zinzani, P. | Tani, M. | Pulsoni, A. | +17

10

MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis : experience on seven patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Derenzini, E. | Fina, M. | Stefoni, V. | +11

CommentIn: Ann Oncol. 2010 Jun;21(6):1141-2. - PMID 19940006